Related posts:
- BRIEF-Moleculin Biotech shares debut at $8.99, above IPO price of $6/shr
- UPDATE 1-Peru’s central bank holds key rate for fourth month in a row
- Moody’s Changes Outlook on Belarus’s Caa1 Government Bond Rating to Stable from Negative; Affirms Caa1 Rating
- Supreme Court agrees to review ATM fee antitrust lawsuit